We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Trauma Audit Filters Trial (TAFT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03235388
Recruitment Status : Enrolling by invitation
First Posted : August 1, 2017
Last Update Posted : September 2, 2021
Sponsor:
Collaborators:
Doctors For You
St Johns Medical College Hospital, Bangalore, India
Seth Sukhlal Karnani Memorial Hospital
Grant Government Medical College & Sir J J Group of Hospitals
Maulana Azad Medical College and Lok Nayak Hospital
Information provided by (Responsible Party):
Martin Gerdin, Karolinska Institutet

Brief Summary:
Audit filters for monitoring trauma care quality are regarded as one of the most essential components of trauma quality improvement programmes; however, there is a paucity of evidence that shows that audit filters are associated with improved outcomes. Therefore, our aim is to assess if institutional implementation of audit filters reduce mortality in adult trauma patients.

Condition or disease Intervention/treatment Phase
Trauma Other: Audit filters Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 8400 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: The Trauma Audit Filters Trial: Does Institutional Implementation of Audit Filters Reduce Mortality in Adult Trauma Patients?
Actual Study Start Date : October 16, 2017
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : December 2023

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intervention
Audit filter implementation in hospital
Other: Audit filters
Institutional implementation of audit filters

No Intervention: Control
Routine care



Primary Outcome Measures :
  1. All cause mortality within 30 days of arrival to participating hospital. [ Time Frame: 30 days ]
    This outcome will be extracted by the project officer from the patient's record as date and time of death or discharge. If the patient is discharged alive before 30 days of arrival the project officer will call the patient or patient relative 30 days after arrival to hospital to establish the patient's status.


Secondary Outcome Measures :
  1. All cause in-hospital mortality [ Time Frame: From arrival to emergency department to discharge from hospital, assessed up to 42 months ]
    This outcome will be extracted by the project officer from the patient's record as date and time of death or discharge.

  2. All cause mortality within 24 hours of arrival to participating hospital. [ Time Frame: 24 hours ]
    This outcome will be extracted by the project officer from the patient's record as date and time of death or discharge. If the patient is discharged alive before 24 hours of arrival the project officer will call the patient or patient relative 24 hours after arrival to hospital to establish the patient's status.

  3. All cause mortality within 90 days of arrival to participating hospital. [ Time Frame: 90 days ]
    This outcome will be extracted by the project officer from the patient's record as date and time of death or discharge. If the patient is discharged alive before 90 days of arrival the project officer will call the patient or patient relative 90 days after arrival to hospital to establish the patient's status.

  4. Quality of life measured using validated translations of the EQ-5D-3L instrument [ Time Frame: 90 days ]
  5. Number of hospital free days to day 30 [ Time Frame: 30 days ]
    Defined as 30 days minus the number of days between arrival to discharge. Date of arrival is observed by the project officer and date of discharge or death is extracted from the patient record. A participant who dies will be assigned 0 as number of hospital free days.

  6. Number of intensive care unit (ICU) free days to day 30 [ Time Frame: 30 days ]
    Defined as 30 days minus the number of days a participant is admitted to an ICU, measured in days from date of ICU admission to date of ICU discharge. Both dates are extracted by the project officer from the patient record. A participant who dies will be assigned 0 as number of ICU free days.

  7. Number of items adhered to in the WHO trauma care checklist [ Time Frame: At the time the participant arrives to emergency department, assessed up to six hours ]
    Recorded by project officers by direct observation



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Admitted to participating centres with history of trauma. History of trauma is here defined as having any of the external causes of morbidity and mortality listed in block V01-Y36, chapter XX of the International Classification of Disease version 10 (ICD-10) codebook as reason for admission.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03235388


Locations
Layout table for location information
India
St John's Medical College Hospital
Bengaluru, India
Maulana Azad Medical College and Lok Nayak Hospital
Delhi, India
Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital
Kolkata, India
Institute is Grant Government Medical College & Sir J J Group of Hospitals
Mumbai, India
Sponsors and Collaborators
Karolinska Institutet
Doctors For You
St Johns Medical College Hospital, Bangalore, India
Seth Sukhlal Karnani Memorial Hospital
Grant Government Medical College & Sir J J Group of Hospitals
Maulana Azad Medical College and Lok Nayak Hospital
Layout table for additonal information
Responsible Party: Martin Gerdin, Researcher, Karolinska Institutet
ClinicalTrials.gov Identifier: NCT03235388    
Other Study ID Numbers: 4-1982/2017
First Posted: August 1, 2017    Key Record Dates
Last Update Posted: September 2, 2021
Last Verified: September 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: The collated data will be de-identified adhering to recognised standards, e.g. applicable parts of the Safe Harbor standard defined in the US Health Insurance Portability and Accountability Act. The de-identified data, from which it will not be reasonable possible to identify individual hospitals or patients, will be uploaded to a public data repository to be used by other researchers. Further, such use will be preceded by the signing of a data sharing agreement, which will include the prohibition of any attempts at re-identification of centres or patients.
Supporting Materials: Study Protocol
Access Criteria: Signing of data sharing agreement

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Martin Gerdin, Karolinska Institutet:
Trauma
Injury
Audit filter
Quality improvement
India
Additional relevant MeSH terms:
Layout table for MeSH terms
Wounds and Injuries